SUNY Upstate Medical University
Syracuse, New York, 13210, United States
NCT Number: NCT03032445
Athletes who are participating in the Keys100 Ultramarathon event in Key West, FL are eligible, based on inclusion criteria, to participate in this research study that is seeking to determine whether supplementation of beer (alcohol) immediately following a long distance ultramarathon race can positively impact exercise-associated hyponatremia [EAH].
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Syracuse, New York, 13210, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subject will be asked to consume alcoholic beer within 30 minutes. Subject will be monitored for 60 minutes at commencement of study beverage.
Subject will be asked to consume non alcoholic beer within 30 minutes. Subject will be monitored for 60 minutes at commencement of study beverage.
Time frame: One hour
Time frame: One hour
Time frame: One hour
Time frame: Within one month of intervention
Cognitive level determined by assessment of clock drawing test.
State University of New York - Upstate Medical University
Other
Potential Impacts of Beer on Post-Race Ultramarathon Athletes
Acronym: BEER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00201994
Brain Diseases, Cardiovascular Diseases
Gustav Carus, Dresden, Germany
View Trial DetailsNCT06781710
Demyelinating Diseases, Hyponatremia
Cologne, Germany
View Trial DetailsNCT01212211
Hyponatremia, Metabolic Diseases
Carentan, France
View Trial DetailsNCT07255833
Arrhythmias, Cardiac, Cardiovascular Diseases
Cologne, Germany
View Trial Details